아미쿠스 테라퓨틱스(Amicus Therapeutics)
US ˙ NasdaqGM ˙ US03152W1099
이 기호는 더 이상 활성화되지 않습니다.

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionMackenzie Financial Corp
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Mackenzie Financial Corp closes position in FOLD / Amicus Therapeutics, Inc.

On May 13, 2026 - Mackenzie Financial Corp filed a 13F-HR form disclosing ownership of 0 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 17,446 shares of Amicus Therapeutics, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -100.00 0
2026-02-18 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 17,446 -130,324 -88.19 248 -78.69 0.0003
2025-11-13 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 147,770 8,563 6.15 1,164 46.05 0.0014
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 139,207 96,602 226.74 798 129.68 0.0010
2025-05-07 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 42,605 20,107 89.37 348 64.45 0.0005
2025-05-02 2024-12-31 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 22,498 -6,379 -22.09 212 -31.49 0.0003
2025-02-20 2024-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 22,498 -6,379 212 0.0003
2025-02-14 2024-12-31 13F Amicus Therapeutics Common Stock 03152W109 22,498 -6,379 182 0.0003
2024-11-13 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 28,877 1,678 6.17 308 14.50 0.0004
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 27,199 191 0.71 270 -15.41 0.0004
2024-05-10 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 27,008 -2,049 -7.05 318 -22.82 0.0005
2024-01-30 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 29,057 4,260 17.18 412 50.92 0.0006
2023-10-25 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 24,797 -18,672 -42.95 274 -48.88 0.0005
2023-08-03 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 43,469 -7,711 -15.07 534 -5.82 0.0008
2023-04-24 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 51,180 8,490 19.89 568 8.83 0.0009
2023-02-14 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 42,690 -14,561 -25.43 521 -12.88 0.0009
2022-10-07 2022-09-30 13F Amicus Therapeutics Common Stock 03152W109 57,251 -21,376 -27.19 598 -29.15 0.0010
2022-08-10 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 78,627 20,750 35.85 844 54.01 0.0014
2022-05-13 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 57,877 -332 -0.57 548 -18.45 0.0007
2022-02-14 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 58,209 -1,026 -1.73 672 18.73 0.0009
2021-11-08 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 59,235 6,513 12.35 566 11.42 0.0008
2021-08-11 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 52,722 16,046 43.75 508 40.33 0.0007
2021-05-14 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 36,676 17,105 87.40 362 -19.91 0.0006
2021-02-10 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 19,571 -39,714 -66.99 452 -46.00 0.0010
2020-11-13 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 59,285 17,460 41.75 837 32.65 0.0021
2020-08-13 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 41,825 41,825 631 0.0017
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.